HEADER VIRAL PROTEIN 19-FEB-20 6LZE
TITLE THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN
TITLE 2 INHIBITOR 11A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 3C-LIKE PROTEINASE;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: PP1AB,ORF1AB POLYPROTEIN,3CL-PRO,3CLP,MAIN PROTEASE,MPRO,
COMPND 5 NON-STRUCTURAL PROTEIN 5,NSP5,SARS CORONAVIRUS MAIN PROTEINASE,
COMPND 6 REPLICASE POLYPROTEIN 1AB;
COMPND 7 EC: 3.4.22.69;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS
SOURCE 3 2;
SOURCE 4 ORGANISM_COMMON: 2019-NCOV;
SOURCE 5 ORGANISM_TAXID: 2697049;
SOURCE 6 GENE: REP, 1A-1B;
SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1
KEYWDS PROTEASE, VIRAL PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR B.ZHANG,Y.ZHANG,Z.JING,X.LIU,H.YANG,H.LIU,Z.RAO,H.JIANG
REVDAT 9 23-OCT-24 6LZE 1 REMARK
REVDAT 8 29-NOV-23 6LZE 1 REMARK
REVDAT 7 10-MAR-21 6LZE 1 COMPND
REVDAT 6 01-JUL-20 6LZE 1 JRNL
REVDAT 5 10-JUN-20 6LZE 1 COMPND
REVDAT 4 03-JUN-20 6LZE 1 REMARK
REVDAT 3 27-MAY-20 6LZE 1 COMPND SOURCE REMARK DBREF
REVDAT 3 2 1 SEQRES HET HETNAM FORMUL
REVDAT 3 3 1 LINK SITE ATOM
REVDAT 2 06-MAY-20 6LZE 1 COMPND SOURCE JRNL DBREF
REVDAT 1 29-APR-20 6LZE 0
JRNL AUTH W.DAI,B.ZHANG,X.M.JIANG,H.SU,J.LI,Y.ZHAO,X.XIE,Z.JIN,J.PENG,
JRNL AUTH 2 F.LIU,C.LI,Y.LI,F.BAI,H.WANG,X.CHENG,X.CEN,S.HU,X.YANG,
JRNL AUTH 3 J.WANG,X.LIU,G.XIAO,H.JIANG,Z.RAO,L.K.ZHANG,Y.XU,H.YANG,
JRNL AUTH 4 H.LIU
JRNL TITL STRUCTURE-BASED DESIGN OF ANTIVIRAL DRUG CANDIDATES
JRNL TITL 2 TARGETING THE SARS-COV-2 MAIN PROTEASE.
JRNL REF SCIENCE V. 368 1331 2020
JRNL REFN ESSN 1095-9203
JRNL PMID 32321856
JRNL DOI 10.1126/SCIENCE.ABB4489
REMARK 2
REMARK 2 RESOLUTION. 1.51 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.12_2829
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.17
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 3 NUMBER OF REFLECTIONS : 57378
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.177
REMARK 3 R VALUE (WORKING SET) : 0.176
REMARK 3 FREE R VALUE : 0.199
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.490
REMARK 3 FREE R VALUE TEST SET COUNT : 2000
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 47.1600 - 3.6272 1.00 4084 148 0.1489 0.1647
REMARK 3 2 3.6272 - 2.8792 1.00 4000 144 0.1786 0.1828
REMARK 3 3 2.8792 - 2.5152 1.00 4002 145 0.1908 0.2280
REMARK 3 4 2.5152 - 2.2853 1.00 3993 144 0.1822 0.1966
REMARK 3 5 2.2853 - 2.1215 1.00 3998 144 0.1733 0.2207
REMARK 3 6 2.1215 - 1.9964 1.00 3974 143 0.1778 0.2089
REMARK 3 7 1.9964 - 1.8964 1.00 4018 145 0.1814 0.2285
REMARK 3 8 1.8964 - 1.8139 1.00 3996 144 0.1784 0.2312
REMARK 3 9 1.8139 - 1.7440 1.00 3985 145 0.1862 0.2218
REMARK 3 10 1.7440 - 1.6838 1.00 3972 143 0.1801 0.2133
REMARK 3 11 1.6838 - 1.6312 1.00 4006 144 0.1900 0.2063
REMARK 3 12 1.6312 - 1.5846 1.00 3935 142 0.2006 0.2326
REMARK 3 13 1.5846 - 1.5428 1.00 3999 146 0.2178 0.2387
REMARK 3 14 1.5428 - 1.5052 0.85 3416 123 0.2896 0.2968
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.410
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 19.14
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.66
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.014 2441
REMARK 3 ANGLE : 1.327 3312
REMARK 3 CHIRALITY : 0.081 371
REMARK 3 PLANARITY : 0.011 427
REMARK 3 DIHEDRAL : 6.211 1419
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): -25.6092 12.8166 59.8900
REMARK 3 T TENSOR
REMARK 3 T11: 0.1048 T22: 0.1434
REMARK 3 T33: 0.1183 T12: -0.0065
REMARK 3 T13: 0.0157 T23: 0.0012
REMARK 3 L TENSOR
REMARK 3 L11: 0.9475 L22: 1.6772
REMARK 3 L33: 2.1945 L12: 0.4589
REMARK 3 L13: 0.0888 L23: 0.7455
REMARK 3 S TENSOR
REMARK 3 S11: 0.0331 S12: -0.0179 S13: -0.0331
REMARK 3 S21: 0.0015 S22: 0.0154 S23: -0.0621
REMARK 3 S31: -0.0336 S32: -0.0055 S33: -0.0520
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6LZE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-FEB-20.
REMARK 100 THE DEPOSITION ID IS D_1300015764.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 02-FEB-20
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : NFPSS
REMARK 200 BEAMLINE : BL19U1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.978
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57378
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500
REMARK 200 RESOLUTION RANGE LOW (A) : 47.165
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0
REMARK 200 DATA REDUNDANCY : 3.287
REMARK 200 R MERGE (I) : 0.04200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.9900
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54
REMARK 200 COMPLETENESS FOR SHELL (%) : 82.2
REMARK 200 DATA REDUNDANCY IN SHELL : 2.75
REMARK 200 R MERGE FOR SHELL (I) : 0.55500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 6LU7
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.78
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2% POLYETHYLENE GLYCOL (PEG) 6000, 3%
REMARK 280 DMSO, 1MM DTT, 0.1M MES BUFFER (PH 6.0), PROTEIN CONCENTRATION
REMARK 280 5MG/ML, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K,
REMARK 280 EVAPORATION
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.84800
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.46900
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.84800
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.46900
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4520 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 25310 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 14.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -42.53247
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 94.33065
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A 532 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 652 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 661 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 702 LIES ON A SPECIAL POSITION.
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 33 -131.23 51.90
REMARK 500 ASP A 48 50.85 -144.23
REMARK 500 ASN A 84 -126.46 54.67
REMARK 500 TYR A 154 -114.34 53.04
REMARK 500
REMARK 500 REMARK: NULL
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: ~{N}-[(2~{S})-3-CYCLOHEXYL-1-OXIDANYLIDENE-1-[[(2~{
REMARK 630 S})-1-OXIDANYLIDENE-3-[(3~{S})-2-OXIDANYLIDENEPYRROLIDIN-3-YL]
REMARK 630 PROPAN-2-YL]AMINO]PROPAN-2-YL]-1~{H}-INDOLE-2-CARBOXAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 FHR A 405
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: ICB ALC ELL
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 403
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue FHR A 405
DBREF 6LZE A 1 303 UNP P0DTD1 R1AB_SARS2 3264 3566
SEQRES 1 A 303 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL
SEQRES 2 A 303 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR
SEQRES 3 A 303 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO
SEQRES 4 A 303 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO
SEQRES 5 A 303 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN
SEQRES 6 A 303 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE
SEQRES 7 A 303 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL
SEQRES 8 A 303 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL
SEQRES 9 A 303 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS
SEQRES 10 A 303 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET
SEQRES 11 A 303 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY
SEQRES 12 A 303 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS
SEQRES 13 A 303 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR
SEQRES 14 A 303 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR
SEQRES 15 A 303 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY
SEQRES 16 A 303 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU
SEQRES 17 A 303 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN
SEQRES 18 A 303 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA
SEQRES 19 A 303 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL
SEQRES 20 A 303 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA
SEQRES 21 A 303 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN
SEQRES 22 A 303 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU
SEQRES 23 A 303 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN
SEQRES 24 A 303 CYS SER GLY VAL
HET DMS A 401 4
HET DMS A 402 4
HET DMS A 403 4
HET DMS A 404 4
HET FHR A 405 33
HETNAM DMS DIMETHYL SULFOXIDE
HETNAM FHR ~{N}-[(2~{S})-3-CYCLOHEXYL-1-OXIDANYLIDENE-1-[[(2~{S})-
HETNAM 2 FHR 1-OXIDANYLIDENE-3-[(3~{S})-2-OXIDANYLIDENEPYRROLIDIN-
HETNAM 3 FHR 3-YL]PROPAN-2-YL]AMINO]PROPAN-2-YL]-1~{H}-INDOLE-2-
HETNAM 4 FHR CARBOXAMIDE
FORMUL 2 DMS 4(C2 H6 O S)
FORMUL 6 FHR C25 H32 N4 O4
FORMUL 7 HOH *209(H2 O)
HELIX 1 AA1 SER A 10 GLY A 15 1 6
HELIX 2 AA2 HIS A 41 CYS A 44 5 4
HELIX 3 AA3 THR A 45 MET A 49 5 5
HELIX 4 AA4 ASN A 53 ARG A 60 1 8
HELIX 5 AA5 SER A 62 HIS A 64 5 3
HELIX 6 AA6 ILE A 200 ASN A 214 1 15
HELIX 7 AA7 THR A 226 TYR A 237 1 12
HELIX 8 AA8 THR A 243 LEU A 250 1 8
HELIX 9 AA9 LEU A 250 GLY A 258 1 9
HELIX 10 AB1 ALA A 260 GLY A 275 1 16
HELIX 11 AB2 THR A 292 CYS A 300 1 9
SHEET 1 AA1 7 VAL A 73 LEU A 75 0
SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73
SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69
SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20
SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O VAL A 35 N LEU A 32
SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38
SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90
SHEET 1 AA2 5 LYS A 100 PHE A 103 0
SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100
SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158
SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150
SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116
SHEET 1 AA3 3 LYS A 100 PHE A 103 0
SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100
SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165
LINK SG CYS A 145 C31 FHR A 405 1555 1555 1.79
SITE 1 AC1 6 GLU A 166 ARG A 188 GLN A 189 THR A 190
SITE 2 AC1 6 GLN A 192 FHR A 405
SITE 1 AC2 7 MET A 6 ALA A 7 PHE A 8 SER A 123
SITE 2 AC2 7 GLN A 127 ARG A 298 HOH A 521
SITE 1 AC3 4 GLY A 15 MET A 17 GLY A 71 LYS A 97
SITE 1 AC4 3 ARG A 40 ASN A 84 CYS A 85
SITE 1 AC5 15 PHE A 140 GLY A 143 SER A 144 CYS A 145
SITE 2 AC5 15 HIS A 163 HIS A 164 MET A 165 GLU A 166
SITE 3 AC5 15 HIS A 172 ASP A 187 ARG A 188 GLN A 189
SITE 4 AC5 15 DMS A 401 HOH A 578 HOH A 631
CRYST1 97.696 80.938 51.738 90.00 114.27 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010236 0.000000 0.004615 0.00000
SCALE2 0.000000 0.012355 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021202 0.00000